Center for Wealth Management Advisory’s Gilead Sciences GILD Stock Holding History

Center for Wealth Management Advisory’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	+13,777	New	+$1.82M	1.09%	29

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Center for Wealth Management Advisory's GILD Position: Q2 2026 in Review

Center for Wealth Management Advisory opened a new position in Gilead Sciences (GILD) in Q2 2026: 13,777 shares worth $1.74M. The stake represents 1.09% of the portfolio and ranks #29 among its holdings.

2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Center for Wealth Management Advisory held 13,777 shares of Gilead Sciences worth $1.74M as of Q2 2026.
Gilead Sciences was a new Center for Wealth Management Advisory position in Q2 2026.
Gilead Sciences made up 1.09% of Center for Wealth Management Advisory's portfolio in Q2 2026, its #29 holding.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Center for Wealth Management Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.